154 results
Page 4 of 8
DEFR14A
r3pa q7zjbkdvvyo
7 May 21
Revised proxy
5:20pm
PRE 14A
25q5 8e6f
26 Apr 21
Preliminary proxy
5:24pm
UPLOAD
apm35k5h1bmbxg
29 Mar 21
Letter from SEC
12:00am
8-K
EX-10.2
prljy 1h9
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.4
hu1r1shmbhm1lr
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.1
vfvauua4ee
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.5
itw5dzi5
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
8-K
EX-10.3
276vdlgz
9 Mar 21
Hoth Therapeutics Announces $15 Million Private Placement
8:30am
UPLOAD
4fyxqr1e
12 Jan 21
Letter from SEC
12:00am
8-K
EX-10.4
rdmkb85a1
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
s399dl
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.3
81ol8r 368jvwap
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.2
gi9gu042e9foxz1thf
8 Jan 21
License Covers Novel Molecular Entity Developed by the Walter Reed Army Institute of Research
4:19pm
8-K
EX-10.1
qdx 8czinfv
21 Sep 20
Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-go COVID-19 Testing Device
4:15pm